# Association between serum level soluble programmed cell death ligand 1 and prognosis in patients with non‐small cell lung cancer treated with <scp>anti‐PD</scp>‐1 antibody

**Type:** Papers  
**Canonical URL:** https://scholariq.org/papers/association-between-serum-level-soluble-programmed-cell-death-ligand-1-and/

## Facts

| Field | Value |
| --- | --- |
| Author Names | Shuji Murakami,Ryota Shibaki,Yuji Matsumoto,Tatsuya Yoshida,Yasushi Goto,Shintaro Kanda,Hidehito Horinouchi,Yutaka Fujiwara,Noboru Yamamoto,Yuichiro Ohe |
| Citations | 56 |
| DOI | 10.1111/1759-7714.13721 |
| Fields | Immunology and Microbiology,Medicine |
| Open Access | true |
| OA Status | gold |
| OA URL | https://doi.org/10.1111/1759-7714.13721 |
| OpenAlex ID | https://openalex.org/W3096798581 |
| PMID | 33108686 |
| Type | article |
| Year | 2020 |

## Paper authors

- [Yuji Matsumoto](https://scholariq.org/researchers/yuji-matsumoto/)

## Paper journal

- [Thoracic Cancer](https://scholariq.org/journals/thoracic-cancer/)

## Paper primary topic

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)

## Paper topics

- [Cancer Immunotherapy and Biomarkers](https://scholariq.org/topics/cancer-immunotherapy-and-biomarkers/)
- [Lung Cancer Research Studies](https://scholariq.org/topics/lung-cancer-research-studies/)
- [Immunotherapy and Immune Responses](https://scholariq.org/topics/immunotherapy-and-immune-responses/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.